Ashit Trivedi
AstraZeneca (United States)(US)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Cardiac pacing and defibrillation studies, Cardiac electrophysiology and arrhythmias, Pharmaceutical studies and practices, Apelin-related biomedical research
Most-Cited Works
- → Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux(2014)192 cited
- → Clinical Pharmacology and Translational Aspects of Bispecific Antibodies(2017)72 cited
- → Drug Discovery and Development - New Advances(2019)60 cited
- → Antitubercular nitrofuran isoxazolines with improved pharmacokinetic properties(2012)46 cited
- → Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011–2017: Lessons Learned for Anticancer Drug Development(2017)42 cited
- → A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients(2022)30 cited
- → Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives(2013)25 cited
- → Effect of Varying Degrees of Renal Impairment on the Pharmacokinetics of Omecamtiv Mecarbil(2021)17 cited
- → Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants(2024)11 cited
- → Dynamic time-kill curve characterization of spectinamide antibiotics 1445 and 1599 for the treatment of tuberculosis(2018)10 cited